^
BIOMARKER:

AR-V7 positive

AR-V7 positive
RCC
abiraterone acetate
Resistant: C3 – Early Trials
AR-V7 positive
Prostate Cancer
cabazitaxel
Sensitive: C3 – Early Trials
AR-V7 positive
Prostate Cancer
docetaxel
Sensitive: C3 – Early Trials
AR-V7 positive
Prostate Cancer
abiraterone acetate
Resistant: C4 – Case Studies